• Users Online:2266
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
DRUG PROVING
Year : 2009  |  Volume : 3  |  Issue : 3  |  Page : 7-13

Cuscuta reflexa: A Double Blind Homoeopathic Pathogenetic Trial


1 Central Council for Research in Homoeopathy headquarters, New Delhi, India
2 Drug Proving Research Unit (H), Kolkata, West Bengal, India

Correspondence Address:
R Shaw
Director General, Central Council for Research in Homeopathy, 61-65, Institutional Area, Opp. D-Block, Janakpuri, New Delhi- 110 058
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Objective: To elicit the pharmacodynamic response of the drug, Cuscuta reflexa (dodder) on healthy human volunteers, in non-toxic doses. Methodology: Drug Cuscuta reflexa was proved through a double-blind method. The homoeopathic preparation of the drug was proved in three potencies (6C, 30C and 200C) on 13 volunteers who were selected and declared apparently healthy during their pre-trial medical examination by specialists and through their routine pathological investigations. The volunteers consumed 56 doses (four doses per day for fourteen days) of each potency (6C, 30C and 200C) in three stages for a varying period. The symptoms generated during the trial period were noted by the volunteers and elaborated and cross-examined by the Proving Master. The data obtained from the Drug Proving Center was compiled at drug proving-cum-data processing cell at Central Council for Research in Homoeopathy (CCRH) headquarters after de-coding the drug. Observation: Out of the 9 volunteers who were on actual drug trial, 8 manifested symptoms. The drug was able to produce symptoms in each potency. Only one symptom appeared in more than one prover. Conclusion: Pharmacodynamic responses elicited during the proving trial will add to the literature available on the drug and benefit the research scholars and clinicians. This also needs verification through clinical trials.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1690    
    Printed72    
    Emailed0    
    PDF Downloaded1406    
    Comments [Add]    

Recommend this journal